Novavax Pharmaceuticals (NVAX. O) took a short dive, widening its decline to 4 percent, as the Wall Street Journal reported that the company's COVID-19 vaccine is unlikely to be approved anytime soon.
2025-04-02 16:21:28
Novavax Pharmaceuticals (NVAX. O) took a short dive, widening its decline to 4 percent, as the Wall Street Journal reported that the company's COVID-19 vaccine is unlikely to be approved anytime soon.
7x24 Newsflash
Hot News
Cryptocurrency Payback Calculator - InstructionsVitalik: "DAO" means "project", "official" means "scam"Backpack Exchange已面向英国用户开放其服务派盾：NIBI同名代币发生Rug Pull，损失约31.39万美元香港金管局推出稳定币发行人沙盒CIAN与Lido合作，在Base上推出wstETH Hyper-Staking VaultGate.io 3月储备金总额突破60亿美元，额外储备金超8亿美元Polyhedra Network已于3月12日16时完成ZK空投快照英FCA：不会反对加密资产相关ETN上市请求BTC流通市值突破1.4万亿美元，续创新高Space Nation将于3月底启动OIK代币空投
Related Recommendations
Cryptocurrency Payback Calculator - InstructionsBackpack Exchange已面向英国用户开放其服务派盾：NIBI同名代币发生Rug Pull，损失约31.39万美元香港金管局推出稳定币发行人沙盒CIAN与Lido合作，在Base上推出wstETH Hyper-Staking VaultGate.io 3月储备金总额突破60亿美元，额外储备金超8亿美元Polyhedra Network已于3月12日16时完成ZK空投快照英FCA：不会反对加密资产相关ETN上市请求BTC流通市值突破1.4万亿美元，续创新高Space Nation将于3月底启动OIK代币空投
